Bharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates.. IndiaTimes
A study from BHU analyzing the lasting impacts of Bharat Biotech's Covaxin found nearly a third of recipients reported adverse events of special interest (AESI)... IndiaTimes
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The.. IndiaTimes
AstraZeneca has globally withdrawn its Covid vaccine, citing commercial reasons. The company voluntarily revoked its marketing authorization and announced the cessation of vaccine production, rendering it unusable. This decision marks a significant development in the global vaccination effort against Covid-19.
#COVID19 #Astrazeneca #COVIDVaccine #Covishield #Worldnews #Indianews #UKCourt #Oneindia #Oneindianews
~PR.320~ED.102~
![AstraZeneca pulls its COVID-19 vaccine from the European market [Video]](https://video.newsserve.net/300/v/20240509/1375060834-AstraZeneca-pulls-its-COVID-19-vaccine-from-the.jpg)
![AstraZeneca requests European authorisation of Covid vaccine be pulled [Video]](https://video.newsserve.net/300/v/20240508/1375014316-AstraZeneca-requests-European-authorisation-of-Covid-vaccine-be.jpg)
![AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court [Video]](https://video.newsserve.net/300/v/20240508/1374973818-AstraZeneca-Withdraws-COVID-19-Vaccine-Globally-Days-After.jpg)
